AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
ANAVEX LIFE SCIENCES CORP.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 28, 2026
$1.25−0.06 (-4.58%)
Close on Oct 19, 2026
- Market cap
- $116.12B
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Anavex Life Sciences from other investors
No posts about AVXL yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.